Bioamber Inc (BIOAQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2012 | 09-2012 | 06-2012 | 03-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -39,539 | -30,194 | -18,540 | -10,131 | 0 |
| Depreciation Amortization | 2,216 | 1,608 | 1,073 | 516 | 0 |
| Income taxes - deferred | 55 | N/A | N/A | N/A | N/A |
| Accounts receivable | -596 | -104 | -335 | -214 | N/A |
| Accounts payable and accrued liabilities | -279 | 519 | 1,235 | 687 | N/A |
| Other Working Capital | -5,793 | -3,922 | -3,414 | -4,635 | 0 |
| Other Operating Activity | 11,659 | 5,558 | 2,981 | 1,390 | 0 |
| Operating Cash Flow | $-32,276 | $-26,535 | $-17,000 | $-12,387 | $0 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -6,630 | -5,777 | -3,520 | -642 | 0 |
| Net Acquisitions | -1,000 | N/A | N/A | N/A | 0 |
| Purchase Of Investment | N/A | -1,000 | -1,000 | -1,000 | N/A |
| Investing Cash Flow | $-7,630 | $-6,777 | $-4,520 | $-1,642 | $0 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 6,694 | 0 | N/A | N/A | N/A |
| Common Stock Issued | 9,978 | 9,978 | 9,978 | 9,978 | N/A |
| Other Financing Activity | 0 | 1,845 | -680 | -32 | 0 |
| Financing Cash Flow | $16,672 | $11,823 | $9,298 | $9,946 | $0 |
| Exchange Rate Effect | 351 | 469 | -113 | -62 | 0 |
| Beginning Cash Position | 47,956 | 47,956 | 47,956 | 47,956 | 0 |
| End Cash Position | 25,072 | 26,936 | 35,622 | 43,811 | 0 |
| Net Cash Flow | $-22,884 | $-21,020 | $-12,334 | $-4,145 | $0 |
| Free Cash Flow | |||||
| Operating Cash Flow | -32,276 | -26,535 | -17,000 | -12,387 | 0 |
| Capital Expenditure | -6,630 | -5,777 | -3,520 | -642 | N/A |
| Free Cash Flow | -38,906 | -32,311 | -20,519 | -13,029 | 0 |